"EPSRC IRC Submission of Evidence to the Select Committee Inquiry into AMR\n&#xa0;\nEPSRC IRC Submission of Evidence to the House of Commons Science &amp; Technology Select Committee Inquiry into Antimicrobial Resistance 6\nth\n November 2013.\n&#xa0;1.0 Executive Summary \n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n2.0 Who we are: We are a new EPSRC Interdisciplinary Research Collaboration\n \n(IRC) \nwhich aims to develop an Early Warning Sensing System for Infectious Diseases. \nThe IRC brings together \nmultidisciplinary teams of \nscientists, engineers and clinicians from UCL, Imperial College, the London School of Hygiene and Tropical Medicine, Newcastle University and Surrey University, together with NHS stakeholders\n,\n UCL Partners, Public Health England and industry partners.\n We are pleased to m\nake a short submission \nto the Select Committ\nee’s inquiry into AMR\n1\n \nand focus on the Committee’s questions regarding gaps in \nour \nknowledge \nof AMR \nand \nrecommend \nprioritizing\n fut\nure\n research\n in next generation diagnostics and surveillance\n.\n&#xa0;\n3.0&#xa0;&#xa0; \nHow has AMR developed in the past decade?&#xa0;\n3.1&#xa0;&#xa0; \nA key factor driving the development of AMR is \nthe lack of rapid diagnostic and \ndisease \nsurveillance technologies \nto \ndetect early-stage infections in community settings.\n1\n-6\n \nThe\n result is that\n worldwide many infections remain undiagnosed or are diagnosed at a late stage. This leads to on-going transmission \nby \npeople\n unaware of their infections\n and\n widespread inappropriate use of antibiotics which fuels drug-\nresistance. Late diagnosis\n also \nlimits\n \nour ability to \nrespond to\n \nemerging \nAMR strains\n.\n&#xa0;\n3.2&#xa0;&#xa0; \nEarly detection plays a crucial role in all treatment and prevention strategies. \nH\nowever,\n current gold-standard diagnostic tests \n(\ne.g. \nRT-PCR and bacterial culture) are slow and \nrequire samples to be sent to specialist laboratories\n. This leads to\n inherent delays between tests, results and clinical interventions. Public health interventio\nn may be further delayed by a \ntime lag of 1-2 weeks\n,\n associated with retrospective surveillance of laboratory tests.\n&#xa0;\n3.3&#xa0;&#xa0; \nThere are national and international drivers to widen access to \nrapid \ntests at the point-of-care (\nPoC\n) but current tests (\ne.g.\n \nlateral flow\n tests\n) are typically not sensitive to early infections\n,\n leading to missed opportunities for interventions.\n6\n \n&#xa0;\n3.4&#xa0;&#xa0; \nMoreover while \nPoC\n tests may speed diagnosis, \nthis data must be captured. I\nf capability to capture information for national and international surveillance is lost, so too will our ability to respond to future threats.\n Therefore future rapid \nPoC\n tests must be sensitive to early infections and combined with data linkage.\n \n&#xa0;\n4.0&#xa0;&#xa0; \nIs there sufficient research and investment into new antibiotics or other treatments and methods to ensure continued protection against infection? If not how could this be rectified?&#xa0;4.1&#xa0;&#xa0; \nIn parallel with the development of new anti\nmicrobials\n, t\nhere is a vital need for\n new technologies to improve the early detection and diagnosis of infections, particularly in community settings. \n&#xa0;\n4.2&#xa0;&#xa0; \nResearch into new diagnostics has traditionally seen under-investment co\nmpared to treatment and vaccine programmes\n but there is a growing realisation that diagnostics are the gateway\n to informing correct treatment\n and prevention strategies\n. Better diagnostics\n will\n \ncurb\n the inappropriate use of antibiotics, in turn preserving their effectiveness\n for future generations\n.\n&#xa0;4.3&#xa0;&#xa0; \nWe welcome the \nGovernment’s \nrecommendation to increase funding \nin this area\n but we note that there is no reference \nin the report \nto EPSRC research.\n1\n \nThere\n is a crucial need for core underpinning engineering and physical sciences research to fuel a pipeline of innovative 21\nst\n century diagnostic and surveillance technologies to prevent the spread of AMR. \nWe recommend prioritising research \nin \ntwo \nkey areas: \n(\ni\n) \nWeb-tracking of infectious diseases across populations; (ii) Rapid Diagnostics with Data Linkage for Community Settings. \n&#xa0;4.4&#xa0;&#xa0; \n Web-tracking of infectious diseases across populations &#xa0;\n4.41\n&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; \nThe Government’s \n5 Year AMR Strategy 2013-18\n \nfocuses on \nimproving \ntraditional surveillance systems.\n1\n In addition, we recommend priorit\nising the use of web-\ninformation\n \nand crowd sourcing \nto improve early detection capabilities\n. \n&#xa0;\n4.42\n&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; \nEvery week millions of people use the internet to search for information about health and self-report symptoms of an illness, often before they visit a doctor. For example, symptoms such as “fever”\n, \n“cough” \nor “\ndiarrhoea\n” \nare investigated using search engines (e.g. Google or Bing), and posted on social \nnetworking\n and \nmicroblogging\n sites (e.g. Twitter). Although not everyone who types in symptoms is actually ill, \na pattern emerges from trends in the total number of \nanonymised\n searches\n and tweets\n.\n \n&#xa0;\n4.43\n&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; \nUp-to-date estimates of outbreaks based on web-information linked to current epidemiological information may enable doctors to better respond to AMR.\n Web-information also has the advantage that it could potentially track infections across a much larger proportion of the population \nthan current surveillance \nand might identify outbreaks even before people attend clinics. \n&#xa0;\n4.44\n&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; \nThe low cost of these methods is likely to be of particular benefit in resource-limited settings such as developing countries, where infectious diseases are an enormous problem. \n&#xa0;\n4.45\n&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; \nWeb information and crowd sourcing has been exploited for the identification of disease outbreaks, such as influenza, at an early stage. Similar tools could be applied to AMR, in combination with rapid diagnostics. \nKey e\nxamples of these technologies \ninclude\n:\n \n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n4.46\n&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; \nM\nore\n \nresearch\n is needed to improve the evidence-base of these potentially highly\n \nvaluable technologies\n and extend their use to AMR\n.\n Future research\n should target tools to improve their accuracy\n, geographical granularity and\n evaluate\n of their cost-effectiveness\n. \n&#xa0;\n4.47\n&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; \nWe would like to highlight o\nne of the key challenges facing the academic community in this area is restricted access to data, such as queries and tweets, held by private companies. New public-private partnerships, policy changes\n, \ngovernance frameworks are urgently required to responsibly develop this powerful resource for AMR, balancing the privacy of individuals with the benefits of research for the public good; \n&#xa0;\n4.48\n&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; \nData linkage to current surveillance systems will \nalso \nbe crucial. \n&#xa0;\n4.49\n&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; \nGlobal coordination and action is urgently required since infectious diseases know no borders. More strategic alignment and investment is needed to support cros\ns border activities and \nglobal networks of excellence. \nIn particular, international web surveillance efforts could be significantly strengthened by a shared open-source software platform that provides the core software platform for national programs and allows national programs to focus on unique requirements, e.g. language.\n&#xa0;\n&#xa0;\n4.5&#xa0;&#xa0; \nRapid Diagnostics with Data Linkage for Community Settings:\n&#xa0;\n4.51\n&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; \nR\napid and accurate identification \nof the underlying agents using diagnostic tests is essential if we are to stop outbreaks with the correct control measures, for instance, containment, confinement, antimicrobials or vaccines. This is particularly true fo\nr emerging resistance\n, where we find ourselves in a race to develop new controls as the disease spreads. \n&#xa0;\n4.52\n&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; \nHowever \ncurrent gold standard tests are laboratory-based and \nthe inherent delays associated with \nsending sample off\n, \nobtaining \ntest \nresults and follow up appointments leads to delays in treatment and prevention strategies\n. \n&#xa0;\n4.53\n&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; \nThe \nGovernment’s 5 Year AMR Strategy 2013-18,\n highlights the urgent need for the deployment of \nPoC\n diagnostics in community settings to speed diagnosis. However, robust, rapid, high-performance \nPoC\n technologies \nmust \nfirst \nbe developed\n to ensure this capability\n. \nThis will \nrequire significant \nfuture \nresearch into\n, for example,\n new biomarkers\n which reduce the need for complex sample preparation steps\n,\n \ngenomics, \ntemperature-stable capture coatings, \nmicro and \nnano\n-\nsensor systems\n with on-chip sample handling capabilities\n, low power microelectronics\n, \nbig data analytics\n and data visualisation tools\n.\n \n8-14\n \n&#xa0;\n4.54\n&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; \nIncreased availability of cost effective and easily deployable testing allows timely, more appropr\niate, and less costly treatment.\n \nI\nt helps to rule out more expensive treatment and overtreatment, reduces \nthe\n cost of treatment complications, and potentially reduces the length of stay in hospital. \nMoving \nearly diagnosis \nin\nto the community – particularly in settings such as residential homes, provides the opportunity for significant reductions in morbidity and mortality.\n&#xa0;\n4.55\n&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; \nA\ns testing becomes more widespread in a variety of non-hospital settings, \nit \nwill become \nvital to\n \nensure information is \ncapture\nd\n for \ndisease \nsurveillance. Rapid diagnostic tests with data linkage, such \nas\n \nsmartphone\n-connected tests, offer huge potential for rapid, real-time, geographically tagged diagnosis. This evidence can be combined with \nweb-tracking efforts to map\n outbreaks at local, national and international levels to support\n early\n public health interventions. \n&#xa0;\n4.56\n&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; \nT\nhe enormous rise in mobile phones and internet usage in \ndeveloped and \ndeveloping countries\n \npresents \nan \nexciting \nopportunity\n to \ndramatically \nwiden access to \n“smart \ndiagnostics \ntests” to\n \nuncover and manage infection worldwide \n- \nfor the common good. \nIn 2013 the International Telecommunications Union estimates that there \nare \n6.8 billion mobile subscriptions \nwith\n rapid expansion in develop\ning countries.\n1\n4\n Widening access to tests in community settings will empower patients to gain faster access to treatment, reduce the inappropriate use of antibiotics and protect the wider public.\n&#xa0;\n4.57\n&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; \nThe rise in mobile health technologies is linked to a much larger trend in patients taking on much more interest and responsibility in their own health. For example, handheld glucose monitoring \ndevices\n \nwith data linkage to doctors \nare the standard of \ncare for patients with diabetes.\n \nMobile tests \nfor AMR \ncould also facilitate two-way interfaces, providing patients with advice on treatment (e.g. encouraging compliance to antibiotic treatment programmes) and relaying public information in the event of a serious outbreak. \n&#xa0;\n4.58\n&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; \nHowever t\nhere \nremain\n major \nscientific and \ntechnological challenges associated with the development of robust, high-performance tests for community settings. \nWe see a need for\n \nmajor programmes of basic research \nat the interface between physical sciences, engineering, life sciences and medicine, to \nsupport technology translation, \nimprove \nregulatory guidance\n \nand the heal\nth economic evaluation of \nnew mobile health technologie\ns\n. \n&#xa0;\n4.59\n&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; \nWe \nalso \nrecommend creating \nAMR Fellowships, \nGrand Challenge \nresearch \nprogrammes\n, \nCentres for Doctoral Training\n and Global networks of excellence\n in AMR\n. Cre\nating the tools, skill-sets, \ntrained \npersonnel\n \nand future leaders in AMR \nwill ensure that the NHS\n is best placed to take advantage of emerging technologies to tackle AMR, and will also provide commercial opportunities for British industry.\n5.0&#xa0;&#xa0; \nReferences&#xa0;\n 483 \nYear published:\n(2013)\n;\n&#xa0;&#xa0;6.0 \nDeclaration of Interests: We are a new EPSRC Interdisciplinary Research Collaboration which aims to develop an Early Warning Sensing System for Infectious Diseases. \nFor more information \nplease contact the IRC \nDirector, \nProfessor Rachel McKendry \n(\nr.a.mckendry@ucl.ac.uk\n) \nand the Strategic Operations Director, Dr Tania \nSaxl\n \n(t.saxl@ucl.ac.uk\n).\n \n2\n&#xa0;\n"